The Federal Trade Commission wants to make changes to the Health Breach Notification Rule to make clear the protections extend to users of digital health apps.
While the agency has considered health trackers, apps and other direct-to-consumer companies subject to the rule, proposed changes…
Source: www.modernhealthcare.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
